Zimmer Biomet Holdings Cost of Goods Sold 2010-2025 | ZBH
Zimmer Biomet Holdings annual/quarterly cost of goods sold history and growth rate from 2010 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Zimmer Biomet Holdings cost of goods sold for the quarter ending March 31, 2025 was $0.550B, a 7.32% increase year-over-year.
- Zimmer Biomet Holdings cost of goods sold for the twelve months ending March 31, 2025 was $2.229B, a 6.37% increase year-over-year.
- Zimmer Biomet Holdings annual cost of goods sold for 2024 was $2.191B, a 5.15% increase from 2023.
- Zimmer Biomet Holdings annual cost of goods sold for 2023 was $2.084B, a 3.18% increase from 2022.
- Zimmer Biomet Holdings annual cost of goods sold for 2022 was $2.02B, a 3.01% increase from 2021.
| Zimmer Biomet Holdings Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $2,191 |
| 2023 | $2,084 |
| 2022 | $2,020 |
| 2021 | $1,960 |
| 2020 | $1,824 |
| 2019 | $2,253 |
| 2018 | $2,272 |
| 2017 | $2,133 |
| 2016 | $2,382 |
| 2015 | $1,801 |
| 2014 | $1,243 |
| 2013 | $1,267 |
| 2012 | $1,125 |
| 2011 | $1,122 |
| 2010 | $1,012 |
| 2009 | $991 |
| Zimmer Biomet Holdings Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $550 |
| 2024-12-31 | $587 |
| 2024-09-30 | $539 |
| 2024-06-30 | $554 |
| 2024-03-31 | $512 |
| 2023-12-31 | $539 |
| 2023-09-30 | $519 |
| 2023-06-30 | $526 |
| 2023-03-31 | $501 |
| 2022-12-31 | $520 |
| 2022-09-30 | $488 |
| 2022-06-30 | $511 |
| 2022-03-31 | $500 |
| 2021-12-31 | $537 |
| 2021-09-30 | $491 |
| 2021-06-30 | $496 |
| 2021-03-31 | $436 |
| 2020-12-31 | $343 |
| 2020-09-30 | $569 |
| 2020-06-30 | $425 |
| 2020-03-31 | $487 |
| 2019-12-31 | $582 |
| 2019-09-30 | $536 |
| 2019-06-30 | $581 |
| 2019-03-31 | $553 |
| 2018-12-31 | $583 |
| 2018-09-30 | $529 |
| 2018-06-30 | $584 |
| 2018-03-31 | $576 |
| 2017-12-31 | $591 |
| 2017-09-30 | $501 |
| 2017-06-30 | $528 |
| 2017-03-31 | $513 |
| 2016-12-31 | $622 |
| 2016-09-30 | $479 |
| 2016-06-30 | $640 |
| 2016-03-31 | $641 |
| 2015-12-31 | $669 |
| 2015-09-30 | $552 |
| 2015-06-30 | $294 |
| 2015-03-31 | $285 |
| 2014-12-31 | $312 |
| 2014-09-30 | $296 |
| 2014-06-30 | $332 |
| 2014-03-31 | $304 |
| 2013-12-31 | $321 |
| 2013-09-30 | $329 |
| 2013-06-30 | $324 |
| 2013-03-31 | $293 |
| 2012-12-31 | $299 |
| 2012-09-30 | $256 |
| 2012-06-30 | $282 |
| 2012-03-31 | $289 |
| 2011-12-31 | $303 |
| 2011-09-30 | $252 |
| 2011-06-30 | $288 |
| 2011-03-31 | $279 |
| 2010-12-31 | $274 |
| 2010-09-30 | $219 |
| 2010-06-30 | $251 |
| 2010-03-31 | $268 |
| 2009-12-31 | $274 |
| 2009-09-30 | $249 |
| 2009-06-30 | $237 |
| 2009-03-31 | $230 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.048B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.811B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |